
Neuro-Oncology Nugget: Targeting CDK8 in MYC-Driven Medulloblastoma
Shahad Abdulsahib discusses the findings of a recent paper, entitled "Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medullobla...
23 Feb 2min

Neuro-Onc Narratives: Patient Services at the American Brain Tumor Association
Dr. Rachna Malani interviews Mindy Freund about her work at the American Brain Tumor Association
20 Feb 19min

Author Interview: Post-irradiation chemotherapy in patients with newly diagnosed ependymoma
Dr. Jasmin Jo interviews Dr. Amy Smith and Dr. David Ellison on their manuscript, entitled "Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a rep...
16 Feb 17min

Hot Topics: How longitudinal profiling of glioma informs therapy development
Dr. Dave Rogawski interviews Dr. David Solomon on his research that sheds light on how key genomic alterations in high-grade glioma evolve over time and how these insights might inform therapeutic dev...
13 Feb 19min

Neuro-oncology Nugget: Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma
Dr. Haseeb Mehmood discusses the use of microbubble-enhanced transcranial focused ultrasound combined with standard temozolomide in high-grade glioma.
9 Feb 3min

SNObound: Career Advice from Neuro-oncologist, Dr. Lisa DeAngelis
Dr. Evan Noch interviews Dr. Lisa DeAngelis about her career in neuro-oncology, role as Chair of Neurology and Physician-in-Chief at Memorial Sloan Kettering Cancer Center, and advice for trainees ent...
6 Feb 34min

Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas
Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled "Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurre...
2 Feb 23min

Introduction to Neuro-Oncology: The Podcast 2.0
In this episode, Dr. Evan Noch and Dr. Maya Graham discuss the exciting new podcast subtypes and the episodes to come.
30 Jan 7min


















